12 results

1 Vaccine industrialization in Korea: focus on major improvements and future direction
Jin Han Kang, Sung-Ho Cha
Clin Exp Vaccine Res. 2013;2(1):1-3.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.1
4 Vaccines today, vaccines tomorrow: a perspective
Christian Loucq
Clin Exp Vaccine Res. 2013;2(1):4-7.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.4
8 Requirements for improved vaccines against foot-and-mouth disease epidemics
Jong-Hyeon Park
Clin Exp Vaccine Res. 2013;2(1):8-18.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.8
19 The present and future of rabies vaccine in animals
Dong-Kun Yang, Ha-Hyun Kim, Kyung-Woo Lee, Jae-Young Song
Clin Exp Vaccine Res. 2013;2(1):19-25.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.19
26 H9N2 avian influenza virus in Korea: evolution and vaccination
Dong-Hun Lee, Chang-Seon Song
Clin Exp Vaccine Res. 2013;2(1):26-33.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.26
34 Current status of vaccine development for tularemia preparedness
Kee-Jong Hong, Pil-Gu Park, Sang-Hwan Seo, Gi-eun Rhie, Kyuh-Jam Hwang
Clin Exp Vaccine Res. 2013;2(1):34-39.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.34
40 Management of vaccine safety in Korea
Young June Choe, Geun-Ryang Bae
Clin Exp Vaccine Res. 2013;2(1):40-45.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.40
46 Current status of registry of vaccine clinical trials conducted by Korean investigators in ClinicalTrials.gov, database of US National Institutes of Health
Jahyang Cho, Bo Bae Kim, Chong-Woo Bae, Sung-Ho Cha
Clin Exp Vaccine Res. 2013;2(1):46-52.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.46
53 Perspectives on vaccine injury compensation program in Korea: the pediatricians' view
Dae Sun Jo, Jung Soo Kim
Clin Exp Vaccine Res. 2013;2(1):53-57.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.53
58 Inactivated pep27 mutant as an effective mucosal vaccine against a secondary lethal pneumococcal challenge in mice
Sang-Yoon Choi, Thao Dang-Hien Tran, David E. Briles, Dong-Kwon Rhee
Clin Exp Vaccine Res. 2013;2(1):58-65.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.58
66 Prolonged shedding of the canine influenza H3N2 virus in nasal swabs of experimentally immunocompromised dogs
Minki Hong, Bokyu Kang, Woonsung Na, Dongjun An, Hyoungjoon Moon, Doo-Jin Kim, Jinsik Oh, Seong-Jun Park, Haryoung Poo, Jeong-Ki Kim, Jongman Kim, Daesub Song
Clin Exp Vaccine Res. 2013;2(1):66-68.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.66
69 Clinical trials for vaccine development in registry of Korea Food and Drug Administration
Seog-Youn Kang
Clin Exp Vaccine Res. 2013;2(1):69-70.   Published online 2013 January 15    DOI: http://dx.doi.org/10.7774/cevr.2013.2.1.69
Articles from Clinical and Experimental Vaccine Research are provided here courtesy of The Korean Vaccine Society